Imatinib (IM) versus hydroxychloroquine (HCQ) and IM for patients with chronic myeloid leukaemia (CML) in cytogenetic response (CyR) with residual disease detectable by quantitative polymerase chain reaction (Q-PCR)
2002 ◽
Vol 118
(3)
◽
pp. 771-777
◽
2000 ◽
Vol 109
(3)
◽
pp. 622-628
◽
2001 ◽
Vol 113
(4)
◽
pp. 1072-1075
◽
1990 ◽
Vol 75
(3)
◽
pp. 355-358
◽
2015 ◽
Vol 100
(Suppl 3)
◽
pp. A172.1-A172